# RETRACTION: Ivermectin Synergizes Sorafenib in Hepatocellular Carcinoma via Targeting Multiple Oncogenic Pathways

PMC · DOI: 10.1002/prp2.70222 · Pharmacology Research & Perspectives · 2026-02-13

## Full-text entities

- **Diseases:** Hepatocellular Carcinoma (MESH:D006528)
- **Chemicals:** Sorafenib (MESH:D000077157), Ivermectin (MESH:D007559)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12905504/full.md

---
Source: https://tomesphere.com/paper/PMC12905504